© 2007 Nature Publishing Group http: www.nature.com naturebiotechnology REVIEW Complement-targeted therapeutics Daniel Ricklin - Complement receptor - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-07-19 16:33:18 Biology Alternative complement pathway Eculizumab Complement control protein Complement component 3 C5-convertase Complement component 5a C3-convertase C1-inhibitor Complement system Anatomy Immune system		© 2007 Nature Publishing Group http://www.nature.com/naturebiotechnology REVIEW Complement-targeted therapeutics Daniel Ricklin & John D Lambris Add to Reading List Source URL: www.nature.com Download Document from Source Website File Size: 1,15 MB Share Document on Facebook

	HUS ParisMode de compatibilité] DocID: 1oXIv - View Document
	Carbinoxaminium dipicrate DocID: RAQt - View Document
	© 2007 Nature Publishing Group http://www.nature.com/naturebiotechnology REVIEW Complement-targeted therapeutics Daniel Ricklin & John D Lambris DocID: QbAx - View Document
	ALN-CC5, an Investigational RNAi Therapeutic Targeting C5 for Complement Inhibition Anna Borodovsky1; Kristina Yucius1; Andrew Sprague1; Nirmal K. Banda2; V. Michael Holers2; Akshay Vaishnaw1; Martin Maier1; Rajeev Kalla DocID: NNEW - View Document
	ISJ 8: 21-32, 2011 ISSN 1824-307X DocID: 4O1s - View Document